Trends and Finance: Page 2

Agilent Technologies, Proscia ink digital pathology distribution agreement

Combining Agilent's pathology staining solutions with Proscia’s Concentriq Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality, Agilent said.

March 8, 2023

Fujifilm Healthcare Americas entering digital pathology, features newly branded solution at USCAP 2023

Fujifilm's solution delivers digital images for diagnosis 1.7 hours faster than glass slides, and facilitates instant sharing of patient cases with subspecialists, allowing for speedier diagnosis and treatment of patients, the firm said.

March 10, 2023

FDA grants clearance to Abbott for first commercial laboratory test to detect traumatic brain injury

The test runs on Abbott's Alinity i laboratory immunoassay instrument, providing a result in 18 minutes to help clinicians quickly assess concussion and triage patients, Abbott said. Negative results rule out the need for a CT scan.

March 7, 2023

Quanterix Q4 revenues drop 15% but match analysts’ expectations

For full-year 2022, total revenue was $105.5 million, a decline of 5% compared with 2021 revenue that included $5.2 million in National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) grant money.

March 6, 2023

Myriad Genetics Q4 revenues rise 11% on strength in hereditary cancer, pharmacogenomics testing

Revenue for the quarter ended December 31 was driven by 16% growth in hereditary cancer testing volumes and 23% growth in volumes for the GeneSight pharmacogenomics test.

March 1, 2023

Pathology services provider PathGroup adopts Proscia digital platform

PathGroup supports more than 15,000 referring physicians and more than 200 hospital customers with diversified laboratory testing services and customer service.

March 1, 2023

Most Popular

Genetic causes identified for three rare diseases

Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease

FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis

Duke University researchers discover biomarkers may identify early pancreatic cancer risk

Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test

Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics

Agilent Technologies Q1 revenues rise 5% on strength in life sciences, applied markets

February 28, 2023

Cardio Diagnostics launches AI-based blood test for the early detection of coronary heart disease

PrecisionCHD is an integrated epigenetic-genetic blood test that uses machine learning for the early detection of coronary heart disease.

February 28, 2023

NanoSpot.ai launches AI-based SARS-CoV-2 antibody test

The test uses an agglutination-based method combined with an artificial intelligence (AI)-enabled mobile application to deliver semi-quantitative antibody test results at the point of care.

February 28, 2023

Roche, CDC expand partnership on HIV and TB support for healthcare systems in critical regions

The public-private partnership, named Lab Networks for Health, aims to improve HIV and TB detection, prevention, and treatment in countries that have been hit hardest by the two diseases.

February 28, 2023

Lucira Health files for bankruptcy despite receiving FDA green light

The firm is seeking a strategic or financial partner for the resumption of manufacturing and development of additional home diagnostic testing products.

February 27, 2023

Opko Health Q4 revenues drop 54% as BioReference business reduces costs

BioReference processed approximately 100,000 COVID-19 PCR tests in the fourth quarter of 2022 compared with 2.7 million tests in the fourth quarter of 2021.

February 24, 2023

Previous Page

Page 2 of 113

Next Page